Physician profile
Noah N Chelliah
NPI 1952485740
$115,215.49
in general payments reported to CMS, 2019-2025
15 companies · $3,307 in 2025
The $3,307 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $48K · 2021: $6,526 · 2022: $5,502 · 2023: $1,440 · 2024: $1,910 · 2025: $3,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,793 · Travel and Lodging: $1,864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,793.45 |
| Travel and Lodging | $1,863.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $114,582.22 | 2019-2025 | Gallant, Accent, Assurity |
| Janssen Pharmaceuticals, INC | $252.32 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $52.78 | 2022-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $51.91 | 2019-2024 | Eliquis |
| Lexicon Pharmaceuticals, INC. | $50.72 | 2023-2024 | Inpefa |
| Astrazeneca Pharmaceuticals LP | $48.55 | 2019-2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $32.39 | 2025 | |
| Itamar Medical INC | $29.65 | 2023 | Watchpatone |
| Novartis Pharmaceuticals Corporation | $23.81 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $16.82 | 2023 | Amvuttra |
| Bridgebio Pharma, INC. | $16.68 | 2025 | Attruby |
| Novo Nordisk INC | $15.39 | 2024 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.34 | 2022 | |
| Boston Scientific Corporation | $13.99 | 2023 | |
| Vifor Pharma, INC. | $13.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noah Chelliah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.